Treprostinil improves hemodynamics and symptoms in children with mild pulmonary hypertension awaiting heart transplantation.
Seth A HollanderMichelle T OgawaRachel K HopperEsther LiuSharon ChenDavid N RosenthalJeffrey A FeinsteinPublished in: Pediatric transplantation (2020)
Treprostinil may be used safely in patients with mild PAH awaiting HT, including those with SV disease. PVR falls without substantial increases in mLA/mPCW pressure. HF symptoms improve in some patients.